Forbion Growth
Investor profile
Venture capital
Forbion Growth has backed 2 European tech companies across 2 funding rounds between 2021 and 2025, joining rounds totalling €203M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
2
distinct rounds
Companies
2
backed
Active span
2021–2025
5 yrs
Total round €
€203M
sum of rounds joined
Deals by year
distinct rounds / yearForbion Growth — deals by year — interactive chart.
Data table
| Forbion Growth — deals by year | |
|---|---|
| 2021 | 1 |
| 2025 | 1 |
Top sectors
by dealsForbion Growth — top sectors — interactive chart.
Data table
| Forbion Growth — top sectors | |
|---|---|
| Healthtech | 2 |
Stages
by dealsForbion Growth — stages — interactive chart.
Data table
| Forbion Growth — stages | |
|---|---|
| Other | 1 |
| Series B | 1 |
Countries
by dealsForbion Growth — countries — interactive chart.
Data table
| Forbion Growth — countries | |
|---|---|
| Netherlands | 2 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Azafaros | Netherlands | 1 | €132M |
| Northsea Therapeutics | Netherlands | 1 | €71M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Azafaros | Series B | €132M | 2025-05 |
| Northsea Therapeutics | Other | €71M | 2021-12 |